BMSEED: News
BMSEED is committed to driving innovation and creating a positive impact on the biomedical research community. Our mission is to develop and provide state-of-the-art devices that empower researchers, biomedical scientists, and healthcare professionals to push the boundaries of scientific discovery. Through our cutting-edge technologies, including stretchable microelectrode arrays and advanced cell-stretching systems, we aim to facilitate more effective and efficient biomedical studies. Our focus is on supporting the advancement of biomedical science, fostering collaboration, and enabling groundbreaking research that can transform healthcare. Whether through partnerships, product innovation, or knowledge sharing, BMSEED is dedicated to shaping the future of biomedicine.
Reach Out to BMSEED
Contact us at BMSEED if you're interested in the MEASSuRE system. Our team will walk you through how this tool can support and enhance your research.
The 10th Federation of the Asian and Oceanian Physiological Societies Congress (#FAOPS)
BMSEED exhibits at The 10th Federation of the Asian and Oceanian Physiological Societies Congress” (#FAOPS) in Daegu, Korea from 1-4 November 2023.
BMSEED Mentoring NIA Startup Challenge
BMSEED will be mentoring at the 2023 NIA Startup Challenge.
BMSEED's Product at the 28th Congress of the European Society of Biomechanics
BMSEED’s products will be featured at the 28th Congress of the European Society of Biomechanics in Maastricht, The Netherlands.
BMSEED at 2023 BRAIN Initiative Meeting
BMSEED is presenting our research products at the BRAIN Initiative Meeting on June 12 and 13, 2023.
BMSEED at 2023 Arizona BioPreneur Conference
BMSEED is presenting at the 2023 Arizona BioPreneur Conference in Downtown Phoenix, Arizona.
BMSEED filed non-provisional patent application for 3D microelectrode array technology
BMSEED filed a non-provisional patent application for 3D stretchable microelectrode array technology.
BMSEED at the Society for Neuroscience Annual Meeting
BMSEED will be exhibiting at the 2022 Society for Neuroscience conference in San Diego, California.
BMSEED at 3rd Symposium on Stem Cell Biology and Regenerative Medicine
The talk is titled “‘Expanding the toolkit of biomedical engineers: Stretchable microelectrodes for in vitro and in vivo applications”.
BMSEED Awarded Fast Track SBIR Grant from NIH
BMSEED was awarded a Fast Track SBIR grant from NIH to develop and commercialize a microfluidic chip-based platform for modeling Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD) for preclinical in vitro mechanistic studies and drug testing.
Dunn Labortechnik is now BMSEED's Distributor for Europe
Dr. Hamza Mohammed from Dunn Labortechnik exhibiting BMSEED’s MEASSuRE platform at the TERMIS conference in Krakau, Poland.
BMSEED files non-provisional patent application for novel peripheral nerve interface
The mcPNI enables reliable, long-term neuromodulation in small peripheral nerves, and integrates a 2-photon 3D printed microclip with BMSEED’s stretchable microelectrode array (sMEA) technology.
BMSEED Chooses Intellectual Property Law Firm BSKB
BMSEED was recently awarded $50,000 from the NIH Small Business Phase II Technical and Business Assistance (TABA) Consulting Services program with the goal to strengthen the company’s IP portfolio.